Differentiation Induction in Acute Myelogenous Leukemia
This study has been completed.
University of Bergen
Information provided by (Responsible Party):
Øystein Bruserud, University of Bergen
First received: September 9, 2005
Last updated: June 23, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||November 2009|
|Primary Completion Date:||May 2008 (Final data collection date for primary outcome measure)|
Ryningen A, Stapnes C, Lassalle P, Corbascio M, Gjertsen BT, Bruserud O. A subset of patients with high-risk acute myelogenous leukemia shows improved peripheral blood cell counts when treated with the combination of valproic acid, theophylline and all-trans retinoic acid. Leuk Res. 2009 Jun;33(6):779-87. doi: 10.1016/j.leukres.2008.10.005.